Leukemia Clinical Trials in Ohio

Showing 1161-1180 of 1,600 trials

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

NCT03127735

To determine the maximum tolerated and / or recommended Phase II dose of oral mutant IDH1 (mIDH1) inhibitor BAY1436032 and to characterize its safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical efficacy in patients with mIDH1-R132X advanced acute myeloid leukemia (AML)

Leukemia, Myeloid, Acute

Bayer27 participantsStarted Jun 2017

Buffalo, New York, United States • New York, New York, United States • The Bronx, New York, United States +10 more locations

COMPLETEDPhase 332 miles

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01846611

The purpose of this study is to assess the efficacy and safety of trabectedin+DOXIL as a third-line chemotherapy regimen (treatment) in patients with platinum-sensitive advanced-relapsed epithelial ovarian, primary peritoneal, or fallopian tube cancer who received 2 previous lines of platinum-based chemotherapy.

Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms

Janssen Research & Development, LLC581 participantsStarted Oct 2013

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +135 more locations

PreviousPage 59 of 80Next

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Leukemia Trials in Other Cities

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Early Diagnosis of Candidiasis in Premature Infants

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Observational Study of Surgical Treatment of Necrotizing Enterocolotis

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

Immunogenicity of PCV-7 Vaccine in VLBW Infants

A Study for Patients With Acute Leukemia

Frequency of Screening and SBT Technique Trial

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell Leukemia

LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

Comparability and Standardization of Controlled Allergen Challenge Facilities

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations

Other Conditions in Ohio